Amlodipine Besylate Tablet
Product Images NDC 67877-902

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 67877-902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine-10mg-1000tabs-cont (Amlodipine 10mg 1000tabs Cont)

Label for Amlodipine Besylate Tablets, USP 10 mg by Ascend Laboratories, LLC. The label indicates 1000 tablets in the package, with dosage form as tablets for oral use. The NDC number is 67877-902-10. Manufacturer is Alkem Laboratories Ltd., Mumbai, India, and distributed by Ascend Laboratories, LLC, Bedminster, NJ. Storage instructions and warnings are included.*

FDA Label Image

Amlodipine-25mg-90tabs-cont (Amlodipine 25mg 90tabs Cont)

Label for Amlodipine Besylate Tablets USP 2.5 mg, oral tablets. The label includes dosage strength (2.5 mg), quantity (90 tablets), and Rx only designation. It shows the NDC number 67877-900 and lists Ascend Laboratories, LLC as the distributor and Alkem Laboratories Ltd. as the manufacturer. Storage instructions and a patient information website URL are also included.*

FDA Label Image

Amlodipine-5mg-500tabs-cont (Amlodipine 5mg 500tabs Cont)

Label for Amlodipine Besylate Tablets USP 5 mg by Ascend Laboratories, LLC. The label states Rx only with a package count of 500 tablets. It includes storage instructions, manufacturer and distributor information, and a barcode. The label design features blue and black text on a white background with the ASCEND logo prominently displayed.*

FDA Label Image

Figure 2 (Amlodipine Fig)

A forest plot showing hazard ratios with 95% confidence intervals comparing Amlodipine versus placebo across various patient subgroups including overall, age groups, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI stent status. The x-axis represents the hazard ratio scale from 0.0 to 2.0.*

FDA Label Image

Figure 1 (Amlodipine Gra)

A Kaplan-Meier event rate graph displaying event rates over time in months for two groups: Amlodipine and Placebo. The graph shows a lower event rate for Amlodipine compared to Placebo, with risk numbers at the bottom and statistical details including p-value, hazard ratio, and confidence interval in a boxed inset.*

FDA Label Image

Amlodipine-str-2 (Amlodipine Str 2)

Chemical structure of amlodipine besylate showing its molecular formula and atomic connectivity including aromatic rings, ester groups, and a sulfonate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.